Get startedLog in
    Picture of Takeda Pharmaceutical logo

    TAK — Takeda Pharmaceutical News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareConservativeLarge CapHigh Flyer
    All News

    Brief: Iambic Announces Collaboration With Takeda To Advance AI-Driven Design Of Small Molecules

    Picture of Takeda Pharmaceutical logoTakeda Pharmaceutical
    09/02/2026 13:00
    Feb 9 (Reuters) - IAMBIC:

IAMBIC: ANNOUNCES COLLABORATION WITH TAKEDA TO ADVANCE AI-DRIVEN DESIGN OF SMALL MOLECULES

IAMBIC: TO RECEIVE UPFRONT, RESEARCH COST, TECHNOLOGY ACCESS PAYMENTS; ELIGIBLE FOR SUCCESS-BASED PAYMENTS THAT COULD EXCEED $1.7 BILLION

IAMBIC: TO PROVIDE TAKEDA ACCESS TO NEURALPLEXER

IAMBIC: ALSO ELIGIBLE TO RECEIVE ROYALTIES ON NET SALES OF ANY PRODUCTS GENERATED FROM COLLABORATION

Further company coverage: 4502.T

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Takeda Pharmaceutical

    See all news